- $11.28bn
- $13.58bn
- $2.86bn
- 76
- 35
- 80
- 70
Annual income statement for Revvity, fiscal year end - December 28th, USD millions except per share, conversion factor applied.
R2022 January 2nd | 2023 December 31st | 2023 January 1st | 2024 December 29th | 2025 December 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,828 | 2,751 | 3,312 | 2,755 | 2,856 |
| Cost of Revenue | |||||
| Gross Profit | 2,434 | 1,540 | 1,990 | 1,538 | 1,564 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,569 | 2,450 | 2,569 | 2,408 | 2,499 |
| Operating Profit | 1,258 | 301 | 743 | 347 | 357 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,204 | 183 | 652 | 316 | 268 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 889 | 180 | 513 | 283 | 240 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 943 | 693 | 569 | 270 | 241 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 943 | 693 | 569 | 270 | 241 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 8.14 | 2.23 | 4.31 | 2.85 | 2.68 |
| Dividends per Share |